Ahmed Zahlan - Author

Ahmed Zahlan

Contributor, The Yuan

Ahmed Zahlan is a Fulbright Visiting Scholar at Columbia Business School, where he is conducting his PhD research on AI healthcare startups. Zahlan is recognized for his groundbreaking work on Glutect, which has earned him several invention prizes, and was named one of the best innovators in Morocco in 2019.

Domain knowledge

AI is advancing preventive medicine, promoting better health

AI draws much attention for transforming areas of healthcare such as cancer treatments and surgery, but its greatest impact lies in keeping more people healthy so they do not need such intervention, argues Ahmed Zahlan, a Fulbright Scholar doing his PhD on AI healthcare startups.

Ahmed Zahlan | Mar 15, 2024

Emerging markets

AI healthcare startups are already having a transformative impact

Most AI-driven healthcare startups are not household names, yet their impact is far from negligible. Ahmed Zahlan, a Fulbright Scholar doing his PhD on AI healthcare startups at the Columbia Business School, assesses the situation and drops some names to keep an eye on.

Ahmed Zahlan | Nov 02, 2023

Emerging markets

Cutting edge technology is driving financial savings for AI in healthcare

Efforts to reform US healthcare have failed to address the causes of its ills - fragmentation, exorbitant costs, inefficiency, fraud, and waste. Ahmed Zahlan, a Fulbright Scholar doing his PhD on AI healthcare at Columbia Business School, offers his take on how to set it right.

Ahmed Zahlan | Jul 28, 2023